Significantly elevated iron-sulfur cluster proteins (ACP1, FDX2, NUBP2, CIAPIN1, ISCA2, NDOR1, and HSPA8) of HCC tissues in our study would be new potential targets of therapeutic drugs for HCC. The gene discussed is FDX2; the disease is hepatocellular carcinoma.